I Yaron

1.6k total citations
48 papers, 1.3k citations indexed

About

I Yaron is a scholar working on Cell Biology, Physiology and Pharmacology. According to data from OpenAlex, I Yaron has authored 48 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cell Biology, 12 papers in Physiology and 11 papers in Pharmacology. Recurrent topics in I Yaron's work include Proteoglycans and glycosaminoglycans research (12 papers), Inflammatory mediators and NSAID effects (11 papers) and Salivary Gland Disorders and Functions (8 papers). I Yaron is often cited by papers focused on Proteoglycans and glycosaminoglycans research (12 papers), Inflammatory mediators and NSAID effects (11 papers) and Salivary Gland Disorders and Functions (8 papers). I Yaron collaborates with scholars based in Israel, United States and Switzerland. I Yaron's co-authors include Michael Yaron, Idit Shirazi, Michal Yaron, Moshe Tishler, Dan Caspi, Frank A. Meyer, U. Zor, Jean‐Michel Dayer, David Levartovsky and Orna Geyer and has published in prestigious journals such as Nature, The Lancet and Ophthalmology.

In The Last Decade

I Yaron

47 papers receiving 1.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
I Yaron 378 301 209 202 186 48 1.3k
G. Smedegård 180 0.5× 349 1.2× 226 1.1× 488 2.4× 167 0.9× 47 1.5k
Idit Shirazi 203 0.5× 237 0.8× 113 0.5× 103 0.5× 86 0.5× 26 739
Masashi Nobunaga 490 1.3× 165 0.5× 322 1.5× 432 2.1× 152 0.8× 83 1.5k
Geeta D. Thakker 260 0.7× 243 0.8× 638 3.1× 163 0.8× 322 1.7× 13 1.7k
R. Lago 488 1.3× 393 1.3× 276 1.3× 210 1.0× 137 0.7× 10 1.6k
Michael Seed 306 0.8× 124 0.4× 610 2.9× 327 1.6× 265 1.4× 53 1.9k
Ricardo Saban 260 0.7× 383 1.3× 481 2.3× 342 1.7× 188 1.0× 65 2.1k
M. Braga 274 0.7× 281 0.9× 211 1.0× 86 0.4× 39 0.2× 44 1.4k
Stephan Seeliger 239 0.6× 207 0.7× 493 2.4× 599 3.0× 60 0.3× 37 2.0k
Charity C. Fox 164 0.4× 498 1.7× 226 1.1× 702 3.5× 69 0.4× 28 1.3k

Countries citing papers authored by I Yaron

Since Specialization
Citations

This map shows the geographic impact of I Yaron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Yaron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Yaron more than expected).

Fields of papers citing papers by I Yaron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I Yaron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Yaron. The network helps show where I Yaron may publish in the future.

Co-authorship network of co-authors of I Yaron

This figure shows the co-authorship network connecting the top 25 collaborators of I Yaron. A scholar is included among the top collaborators of I Yaron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I Yaron. I Yaron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Litinsky, Ira, Itshak Golan, Michael Yaron, et al.. (2009). Simvastatin Induces Apoptosis of Fibroblast-Like Synoviocytes. The Open Rheumatology Journal. 3(1). 35–40. 6 indexed citations
2.
Levartovsky, David, Irena Wigler, Irving Kaufman, et al.. (2006). The effects of leflunomide on clinical parameters and serum levels of IL-6, IL-10, MMP-1 and MMP-3 in patients with resistant rheumatoid arthritis. Cytokine. 33(2). 106–110. 41 indexed citations
4.
Shirazi, Idit, I Yaron, Yoram Wollman, et al.. (2001). Down regulation of interleukin 1β production in human osteoarthritic synovial tissue and cartilage cultures by aminoguanidine. Annals of the Rheumatic Diseases. 60(4). 391–394. 11 indexed citations
5.
Elkayam, Ori, I Yaron, Idit Shirazi, Michal Yaron, & Dan Caspi. (2000). Serum levels of IL-10, IL-6, IL-1ra, and sIL-2R in patients with psoriatic arthritis. Rheumatology International. 19(3). 101–105. 58 indexed citations
6.
Elkayam, Ori, I Yaron, Idit Shirazi, Michal Yaron, & Dan Caspi. (2000). Serum Levels of Hyaluronic Acid in Patients with Psoriatic Arthritis. Clinical Rheumatology. 19(6). 455–457. 17 indexed citations
7.
Tishler, Moshe, I Yaron, Idit Shirazi, David Levartovsky, & Michal Yaron. (1999). Salivary and serum soluble interleukin-2 receptor in primary Sjögren’s syndrome. Archives of Oral Biology. 44(4). 305–308. 11 indexed citations
8.
Yaron, Michael, Idit Shirazi, & I Yaron. (1999). eAnti-interleukin-1 effects of diacerein and rhein in human osteoarthritic synovial tissue and cartilage cultures. Osteoarthritis and Cartilage. 7(3). 272–280. 81 indexed citations
9.
Tishler, Moshe, et al.. (1999). Increased salivary interleukin-6 levels in patients with primary Sjögren's syndrome. Rheumatology International. 18(4). 125–127. 40 indexed citations
10.
Tishler, Moshe, I Yaron, Idit Shirazi, & Michal Yaron. (1998). Salivary and serum hyaluronic acid concentrations in patients with Sjögren's syndrome. Annals of the Rheumatic Diseases. 57(8). 506–508. 15 indexed citations
11.
Yaron, Michal, Idit Shirazi, & I Yaron. (1997). Effets anti-interleukine 1 de la diacerhéine in vitro.. La Revue du praticien. 47(17). 20–23. 1 indexed citations
12.
Tishler, Moshe, I Yaron, Idit Shirazi, & Michael Yaron. (1997). Saliva: an additional diagnostic tool in Sjögren's syndrome. Seminars in Arthritis and Rheumatism. 27(3). 173–179. 31 indexed citations
13.
Meyer, F., et al.. (1996). Differential effects of 1,25-(OH)2D3 on acyl hydrolase and cyclooxygenase activities in Interleukin 1β-stimulated human synovial fibroblast cultures. Prostaglandins Leukotrienes and Essential Fatty Acids. 55(3). 191–194. 2 indexed citations
14.
Yaron, I, et al.. (1993). Effect of 1,25-dihydroxyvitamin D3 on interleukin 1 beta actions and cell growth in human synovial fibroblast cultures.. PubMed. 20(9). 1527–32. 8 indexed citations
16.
Seckinger, P, I Yaron, Frank A. Meyer, Michael Yaron, & Jean‐Michel Dayer. (1990). Modulation of the effects of interleukin‐1 on glycosaminoglycan synthesis by the urine‐derived interleukin‐1 inhibitor, but not by interleukin‐6. Arthritis & Rheumatism. 33(12). 1807–1814. 34 indexed citations
17.
Yaron, I, Frank A. Meyer, Jean‐Michel Dayer, Ilan Bleiberg, & Michael Yaron. (1989). Some recombinant human cytokines stimulate glycosaminoglycan synthesis in human synovial fibroblast cultures and inhibit it in human articular cartilage cultures. Arthritis & Rheumatism. 32(2). 173–180. 49 indexed citations
18.
Meyer, F., I Yaron, & Michal Yaron. (1987). Stimulation of collagenase production in human synovial fibroblast cultures by poly (I). poly (C).. PubMed. 14(3). 429–34. 2 indexed citations
19.
Yaron, Michal, et al.. (1976). The effect ofd-penicillamine on fibroblast-leukocyte interaction in vitro. Inflammation. 1(3). 231–235. 1 indexed citations
20.
Yaron, Michal, I Yaron, & D. Allalouf. (1972). Effect of ionizing irradiation on hyaluronic acid production by cultured human synovial fibroblasts.. PubMed. 8(10). 1751–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026